ProShare Advisors
QTTB icon

ProShare Advisors’s Q32 Bio QTTB Stock Holding History

ProShare Advisors’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-765
Closed -$42K – 2163
2022
Q1 		$42K Sell
765
-191
-20% -$11.9K ﹤0.01% 2126
2021
Q4 		$62K Sell
956
-20
-2% -$1.94K ﹤0.01% 2260
2021
Q3 		$138K Sell
976
-198
-17% -$25.2K ﹤0.01% 1860
2021
Q2 		$154K Buy
1,174
+321
+38% +$40.1K ﹤0.01% 2211
2021
Q1 		$144K Buy
853
+47
+6% +$9.9K ﹤0.01% 2116
2020
Q4 		$164K Buy
806
+170
+27% +$32.9K ﹤0.01% 1903
2020
Q3 		$122K Sell
636
-22
-3% -$4.93K ﹤0.01% 1507
2020
Q2 		$180K Buy
+658
New +$175K ﹤0.01% 1488
2020
Q1 		– Sell
-716
Closed -$267K – 1620
2019
Q4 		$267K Sell
716
-102
-12% -$29.2K ﹤0.01% 1415
2019
Q3 		$267K Buy
818
+10
+1% +$3.4K ﹤0.01% 1290
2019
Q2 		$285K Sell
808
-3
-0.4% -$1.18K ﹤0.01% 1273
2019
Q1 		$405K Buy
811
+4
+0.5% +$1.79K ﹤0.01% 1112
2018
Q4 		$325K Buy
+807
New +$305K ﹤0.01% 1109

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ProShare Advisors's QTTB Position: Q2 2022 in Review

ProShare Advisors sold out of Q32 Bio (QTTB) in Q2 2022, closing a stake of 765 shares — an estimated $42K sold.

ProShare Advisors first reported a position in QTTB in Q4 2018 and held it in 13 quarters. The position peaked at $405K in Q1 2019. 87 funds tracked by Wall St. Rank hold QTTB as of Q2 2022.

  • ProShare Advisors reported no remaining Q32 Bio position as of Q2 2022 after selling out during the quarter.
  • ProShare Advisors sold 765 Q32 Bio shares in Q2 2022, an estimated $42K.
  • ProShare Advisors first reported a position in Q32 Bio in Q4 2018 and held it in 13 quarters.
  • ProShare Advisors's Q32 Bio position peaked at $405K in Q1 2019.
  • 87 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2022.

Based on ProShare Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.